[The use of enterosorbent SKN in hyperlipoproteinemias (clinical and experimental research)].
Sledzevskaia
I K
IK
Bratus'
V V
VV
Babov
K D
KD
Bul'da
V I
VI
Strelko
V V
VV
Voronkov
G S
GS
Evstratova
I N
IN
Sergienko
O V
OV
Taranenko
V M
VM
Isaechkina
I M
IM
D000328:Adult; D000818:Animals; D001011:Aorta / Q000503:physiopathology; D001161:Arteriosclerosis / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D003131:Combined Modality Therapy; D004036:Diet, Atherogenic; D016061:Enterosorption / Q000379:methods*; D005069:Evaluation Studies as Topic; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000209:etiology / Q000628:therapy; D011817:Rabbits; D013997:Time Factors
Primenenie énterosorbenta SKN pri giperlipoproteidemiiakh (kliniko-éksperimental'noe issledovanie).